Joseph Harry Antin, MD
NPI 1861469249ActiveIndividual· Internal Medicine, Hematology· Boston, MA
Internal Medicine, Hematology (MD) in Boston, Massachusetts, trained at Js Weill Medical College, Cornell University (class of 1978). Their prescriptions cost Medicare Part D more than their services did: $3,788,453 for 520 claims, against $13,379 paid for services in 2024. Janssen Research & Development, LLC was the largest of 6 companies reporting payments in 2025, $14,018 in all, mostly consulting fees.
Overview
| NPI | 1861469249 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Mar 3, 2006 |
| Last updated in NPPES | May 11, 2026 |
| Certified by provider | May 11, 2026 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Hematology Primary | 207RH0000X | 55573 | MA |
| Internal Medicine, Medical Oncology | 207RX0202X | 55573 | MA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 4, 2026 | No match | — |
| New York OMIG · Nov 4, 2026 | No match | — |
| Ohio Medicaid · Nov 4, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 4, 2026 | No match | — |
| Washington HCA · Nov 4, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Hematopoietic Cell Transplantation and Cellular Therapy (MA) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 70 |
|---|---|
| Services billed | 160 across 6 procedure codes |
| Paid by Medicare | $13,379 |
Part D prescriptions in 2024
| Prescriptions (claims) | 520 · 828 30-day fills |
|---|---|
| Patients | 78 |
| Total drug cost | $3,788,453 |
| Generic share | 62% of claims |
Education and affiliations
| Medical school | Js Weill Medical College, Cornell University |
|---|---|
| Graduation year | 1978 |
| Medicare specialty | Hematopoietic Cell Transplantation And Cellular Therapy |
| Secondary specialties | Hematology, Medical Oncology |
Medical group
- Dana-Farber Cancer Institute, Inc.Boston, MA · 684 clinicians
Hospital affiliation
- Brigham and Women's HospitalBoston, MA
Industry payments (Open Payments)
- 2025$14,018 · 13 payments from 6 companies
- 2024$18,360 · 23 payments from 11 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Janssen Research & Development, LLC | $5,550 | 4 |
| Alexion Pharmaceuticals, Inc. | $5,121 | 4 |
| Csl Behring | $1,875 | 2 |
| Glaxosmithkline, LLC. | $750.00 | 1 |
| Gamida Cell Inc. | $500.00 | 1 |
What the 2025 payments were for
- Consulting Fee$13,745 · 9 payments
- Food and Beverage$273.44 · 4 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Hematology providers in Boston
- 1285058321
- 1376232215
- 1083935878
- 1982133658
- 1154997823
- 1356492011
- 1619046604
- 1629069075
- 1609855576
- 1093945396
- 1285642298
- 1295710341
All Internal Medicine, Hematology providers in Massachusetts →